{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:38:39Z","timestamp":1777365519937,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Testing and Analysis"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    3,4\u2010Methylenedioxymethamphetamine (MDMA) remains unapproved for therapeutic use despite the promising results of MDMA\u2010assisted psychotherapy. There is a need to better understand the safety, pharmacokinetics, and toxicology of possible MDMA\u2010based prodrugs. Like lisdexamfetamine, amino acid prodrugs of MDMA may enable more controlled systemic exposure, but their metabolic activation pathways and metabolites are not known yet. This study investigated the bioactivation and metabolism of the MDMA prodrugs, MDMA\u2010tryptophan (MDMA\u2010Trp), MDMA\u2010lysine (MDMA\u2010Lys), and MDMA\u2010glycine (MDMA\u2010Gly), in zebrafish embryos (ZE), pooled human liver S9 fraction (pHLS9), pooled fresh human whole blood (pFHWB), and human urine after microdosing (HMD). It elucidated mechanistic activation routes and identified screening targets relevant for drug testing and safety assessment. In ZE, MDMA\u2010Trp underwent hydroxylation and\n                    <jats:italic>N<\/jats:italic>\n                    \u2010dealkylation prior to amide cleavage, indicating a stepwise bioactivation pathway that differs from direct conversion observed for the other prodrugs. All three prodrugs were cleaved to MDMA in ZE, pHLS9, and HMD, with known MDMA metabolites additionally formed in ZE and pHLS9, whereas no metabolites were detected in pFHWB, suggesting that amide cleavage is not mediated in blood under the tested conditions. Unique urine screening targets were identified only for MDMA\u2010Trp, while biomarkers for MDMA\u2010Lys and MDMA\u2010Gly consisted of MDMA and known MDMA metabolites. This study demonstrated conversion of amino acid prodrugs to MDMA in pHLS9\u2010 and ZE\u2010based systems and in humans after microdosing, but not in blood. There is a need for further studies such as their pharmacokinetic profiles in humans.\n                  <\/jats:p>","DOI":"10.1002\/dta.70057","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T23:54:51Z","timestamp":1773618891000},"page":"669-677","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioactivation and Metabolism of Amino Acid MDMA Prodrugs in Zebrafish Embryos, Human Liver S9, Whole Blood, and Microdosed Human Urine"],"prefix":"10.1002","volume":"18","author":[{"given":"Simon\u00a0K.","family":"Wellenberg","sequence":"first","affiliation":[{"name":"Department of Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH) Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7470-7912","authenticated-orcid":false,"given":"Lea","family":"Wagmann","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH) Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias\u00a0D.","family":"Kroesen","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH) Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Schippers","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH) Saarland University  Homburg Germany"},{"name":"Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Saarland University  Saarbr\u00fccken Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Grill","sequence":"additional","affiliation":[{"name":"MiHKAL GmbH  Allschwil Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Herrmann","sequence":"additional","affiliation":[{"name":"Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) Saarland University  Saarbr\u00fccken Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-6784","authenticated-orcid":false,"given":"Markus\u00a0R.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH) Saarland University  Homburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010023\u201002565\u20104"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215\u20100366(18)30135\u20104"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23092318"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026621666210602154438"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261\u2010015\u20100354\u2010y"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093841"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/bcp.70140"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpc.2018.06.005"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2011.06.121"},{"key":"e_1_2_10_11_1","volume-title":"ICH Guideline M3(R2) on Non\u2010Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorisation for Pharmaceuticals","author":"EMA","year":"2009"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2355"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00539"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204\u2010016\u20101812\u2010x"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00204\u2010025\u201003965\u2010w"},{"issue":"1","key":"e_1_2_10_16_1","first-page":"1","article-title":"Effect of Common Organic Solvents on In\u00a0Vitro Cytochrome P450\u2010Mediated Metabolic Activities in Human Liver Microsomes","volume":"26","author":"Chauret N.","year":"1998","journal-title":"Drug Metabolism and Disposition"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S70382"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa010"},{"key":"e_1_2_10_19_1","volume-title":"Maurer\/Meyer\/Helfer\/Weber MMHW LC\u2010HR\u2010MS\/MS Library of Drugs, Poisons, and Their Metabolites","author":"Maurer H. H.","year":"2018"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150197"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2014.02.014"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691\u2010200404000\u201000009"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.172254"}],"container-title":["Drug Testing and Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.70057","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/dta.70057","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/dta.70057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T07:37:42Z","timestamp":1777361862000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/dta.70057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/dta.70057"],"URL":"https:\/\/doi.org\/10.1002\/dta.70057","archive":["Portico"],"relation":{},"ISSN":["1942-7603","1942-7611"],"issn-type":[{"value":"1942-7603","type":"print"},{"value":"1942-7611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"2025-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}